HLN logo

Haleon plc

HLN
Healthcare|Drug Manufacturers - Specialty & Generic|GB
$9.14
-0.01 (-0.11%)
DCF Value
$18.67
Graham Number
$2.74
Cash / Share
$0.19

About

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

Stock Price

-2.9%(1Y)
1M
-1.3%
3M
-8.9%
6M
+0.3%
YTD
-9.6%
1Y
-4.5%
3Y
+13.0%
5Y
+21.9%

Pipeline Summary

73 total trials
9
Phase 1
0
Phase 2
5
Phase 3
7
Phase 4
Completed: 56Recruiting: 10By Invitation: 1Unknown: 2Active: 1Not Yet Recruiting: 3

Active Trials (11)

A Study to Assess the Efficacy of a Calcium Sodium Phosphosilicate Toothpaste for the Relief of Dentine Hypersensitivity
NCT07894796Dentin Sensitivity
N/ARecruiting
Enrollment: 192 participants
Impact of Supplementation in Improving Metabolic Health Outcomes (ISMOS) Study
NCT07433049Glucose Control
N/ARecruiting
Enrollment: 400 participants
A Study Investigating Gingival Crevicular Fluid Biomarkers Following Use of a Commercially Available Toothpaste Containing Stannous Fluoride
NCT07842042Dental Plaque
N/ARecruiting
Enrollment: 20 participants
Multivitamin and Mineral Supplementation and Healthy Aging
NCT07642869Healthy Aging
N/ARecruiting
Enrollment: 150 participants
The Study to Evaluate the Plaque Control and Anti-Gingivitis Efficacy of a Toothpaste in Chinese Population
NCT07816406Dental Plaque
N/ARecruiting
Enrollment: 120 participants

Key Facts

Market Cap$40.19B
Employees0
CEOBrian James McNamara
IPO DateJul 25, 2022
Beta0.24
52-Week Range$8.38 – $11.28
Avg Volume15,524,349
ExchangeNYSE
Websitehaleon.com

Ownership

Float100.5%
Shares Outstanding4397.6M

Peers

CHDChurch & Dwight Co., Inc.
$25.81B
CLColgate-Palmolive Company
$76.76B
GALD.SWGalderma Group AG
$44.71B
GSKGSK plc
$102.02B
KVUEKenvue Inc.
$37.09B
PRGOPerrigo Company plc
$2.20B
SDZNYSandoz Group AG
$43.69B
Data last updated: Nov 9, 2026, 04:13 AM